Skip to main content
. 2007 Oct 1;9(10):760–769. doi: 10.1111/j.1524-6175.2007.07244.x

Table II.

Change in Daytime and Nighttime Ambulatory SBP Level

Variable No. Darusentan No. Placebo
Baseline
 Mean daytime SBP, mm Hg 76 139.3±1.6 39 141.3±2.2
 Mean nighttime SBP, mm Hg 75 127.6±1.6 39 131.9±3.2
 Mean daytime‐nighttime SBP ratio 75 7.8±0.9 39 6.9±1.2
Week 10 (300‐mg dose)
 Mean daytime SBP, mm Hg 64 129.5±1.6 33 139.3±2.3
 Mean nighttime SBP, mm Hg 63 117.1±1.8 31 129.6±2.7
 Mean daytime‐nighttime SBP ratio 63 9.5±1.0a 31 6.7±1.1
Mean change from baseline to week 10
 Daytime SBP, mm Hg 64 −10.6±1.4b 33 −2.2±2.3
 Nighttime SBP, mm Hg 62 −11.9±1.6b 31 −3.3±2.6
Data are means ± SE. Mean daytime systolic blood pressure (SBP) was defined as the average ambulatory SBP level between 6 pm and 10 pm. Mean nighttime SBP was defined as the average ambulatory SBP level between 10 pm and 6 am. Daytime‐nighttime SBP ratio was calculated as the difference between mean daytime SBP level and mean nighttime SBP level divided by mean daytime SBP level and was expressed as a percentage. a P=.057 unadjusted for multiple comparisons. b P<.001 unadjusted for multiple comparisons.